Cover Image

Plant-Based Recombinant Vaccine: Fact or Fiction?

Amir Ghaffar Shahriari, Maziar Habibi-Pirkoohi

In the era of recombinant DNA technology, production of recombinant vaccines in green plants has emerged as an effective approach addressing the problems of traditional vaccine production. Various antigens expressed in different plant species have been so far tested for the production of efficient oral vaccines against human and livestock diseases. However, recombinant vaccines have not yet found a prominent place in pharmaceutical market. There are still many challenges to be addressed to pave the road for commercial production of plant-based recombinant vaccines. Regarding increasing growth in laboratory studies and field trials for development of plant-based vaccines, this review paper provides a comprehensive overview on the topic of plant-derived vaccines and related issues. [GMJ.2017;6(4):268-80] DOI:10.22086/gmj.v6i3.792

Recombinant; Vaccine; Plant

Obembe OO, Popoola JO, Leelavathi S, Reddy SV. Advances in plant molecular farming. Biotechnol Adv. 2011;29(2):210-22.

Marsian J, Lomonossoff GP. Molecular pharming—VLPs made in plants. Curr Opin Biotechnol. 2016;37:201-6.

Sala F, Rigano MM, Barbante A, Basso B, Walmsley AM, Castiglione S. Vaccine antigen production in transgenic plants: strategies, gene constructs and perspectives. Vaccine. 2003; 21(7):803-8.

Salyaev RK, Rigano MM, Rekoslavskaya NI. Development of plant-based mucosal vaccines against widespread infectious diseases. Expert Rev Vaccines. 2010 ;9(8):937-46.

Schillberg S, Twyman RM, Fischer R. Opportunities for recombinant antigen and antibody expression in transgenic plants—technology assessment. Vaccine. 2005; 23(15):1764-9.

Awale MM, Mody SK, Dudhatra GB, Kumar A, Patel HB, Modi CM, Kamani DR, Chauhan BN. Transgenic Plant Vaccine: A Breakthrough in Immunopharmacotherapeutics. J Vaccines Vaccin. 2012; 3:147.

Franklin SE, Mayfield SP. Prospects for molecular farming in the green alga Chlamydomonas reinhardtii. Curr Opin Plant Biol. 2004;7(2):159-65.

Roy Curtiss II, Cardineau GA, inventors; Washington University, assignee. Oral immunization by transgenic plants. United States patent US 5,654,184. 1997.

Kapusta J, Modelska A, Pniewski T, Figlerowicz M, Jankowski K, Lisowa O, Plucienniczak A, Koprowski H, Legocki AB. Oral immunization of human with transgenic lettuce expressing hepatitis B surface antigen. Progress in Basic and Clinical Immunology 2001 (pp. 299-303). Springer US.

McGarvey PB, Hammond J, Dienelt MM, Hooper DC, Fu ZF, Dietzschold B, Koprowski H, Michaels FH. Expression of the rabies virus glycoprotein in transgenic tomatoes. Biotechnol. 1995;13(12):1484-7.

Hefferon K. Plant‐derived pharmaceuticals for the developing world. Biotechnol J. 2013; 8(10):1193-202.

Pniewski T. The Twenty-Year Story of a Plant-Based Vaccine Against Hepatitis B: Stagnation or Promising Prospects? Int J Mol Sci. 2013; 14:1978-98.

Fischer R, Emans NJ, Twyman RM, Schillberg S. Molecular farming in plants: technology platforms. Enc Plant Crop Sci. 2004:753-6.

Lal P, Ramachandran VG, Goyal R, Sharma R. Edible vaccines: Current status and future. Indian J Med Microbiol. 2007; 25:93-102.

Habibi-Pirkoohi M, Zibaee S. Plant based recombinant vaccines. Inter J Agr Crop Sci. 2013; 6(1):27-31.

Rybicki EP, Martin DP. Virus-derived ssDNA vectors for the expression of foreign proteins in plants. Curr Top Microbiol Immunol. 2014; 375:19–45.

Dugdale B; Mortimer CL, Kato M, James TA, Harding RM, Dale JL. Design and construction of an in-plant activation cassette for transgene expression and recombinant protein production in plants. Nat. Protoc. 2014; 9:1010–27.

Wigdorovitz A, Carrillo C, Dus Santos MJ, Trono K, Peralta A, Gomez M, et al. Induction of a Protective Antibody Response to Foot and Mouth Disease Virus in Mice Following Oral or Parenteral Immunization with Alfalfa Transgenic Plants Expressing the Viral Structural Protein VP1. Virology. 1999; 255: 347-53.

Lee RW, Strommer J, Hodgins D, Shewen PE, Niu Y, Lo RY. Towards development of an edible vaccine against bovine pneumonic pasteurellosis using transgenic white clover expressing a Mannheimia haemolytica A1 leukotoxin 50 fusion protein. Infect Immun. 2001; 69(9):5786-93.

Yusibov V, Modelska A, Steplewski K, Agadjanyan M, Weiner D, Hooper DC, et al. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1. Proc Natl Acad Sci USA. 1997; 94(11): 5784-8.

Karasev AV, Foulke S, Wellens C. Plant based HIV-1 vaccine candidate: Tat protein produced in spinach. Vaccine. 2005; 23(15):1875-80.

Jani D, Meena LS, Rizwan-ul-Haq QM, Singh Y, Sharma AK, Tyagi AK. Expression of cholera toxin B subunit in transgenic tomato plants. Transgenic Res. 2002; 11(5):447-54.

Sandhu JS, Krasnyanski SF, Domier LL, Korban SS, Osadjan MD, Buetow DE. Oral immunization of mice with transgenic tomato fruit expressing respiratory syncytial virus-F protein induces a systemic immune response. Transgenic Res. 2000; 9(2):127-35.

Sharma MK, Singh NK, Jani D, Sisodia R, Thungapathra M, Gautam JK, et al. Expression of toxin co-regulated pilus subunit A (TCPA) of Vibrio cholerae and its immunogenic epitopes fused to cholera toxin B subunit in transgenic tomato (Solanum lycopersicum). Plant Cell Rep. 2008; 27(2):307-18.

Mason HS, Haq FA, Clement JD. Edible vaccine protects mice against Escherichia Coli het labile enterotoxin (LT): Potatoes expressing a synthetic LT-B Gene. Vaccine 1998; 16:1336-43.

Yu J, Langridge WH. A plant-based multicomponent vaccine protects mice from enteric diseases. Nat Biotechnol. 2001; 19(6):548-52.

Dong H, Zhao Y, Wang Y, Li H. Recombinant proteins expressed in lettuce. Ind J Biotechno.l 2014; 13:427-36.

Rosales-Mendoza S, Soria-Guerra RE, Moreno-Fierros L, Han Y, Alpuche-Solís AG, Korban SS. Transgenic carrot tap roots expressing an immunogenic F1-V fusion protein from Yersinia pestis are immunogenic in mice. J Plant Physiol. 2011; 168(2):174-80.

Lamphear BJ, Jilka JM, Kesl L, Welter M, Howard JA, Streatfield SJ. A corn-based delivery system for animal vaccines: an oral transmissible gastroenteritis virus vaccine boosts lactogenic immunity in swine. Vaccine. 2004; 22(19), 2420-4.

Stoger E, Sack M, Perrin Y, Vaquero C, Torres F, Twyman R, et al. Practical considerations for pharmaceutical antibody production in different crop systems. Mol. Breeding. 2002; 9(3): 149–58.

Habibi-Pirkoohi M, Malekzadeh-Shafaroudi S, Marashi H, Moshtaghi N, Nassiri M, Mohkami A, et al. Expression of foot and mouth disease virus (FMDV) capsid protein VP1 in Chlamydomonas reinhardtii as a possible source of recombinant vaccine. Int J Plant Anim Env Sci. 2014; 4(2): 644-8.

Sun M, Qian K, Su N, Chang H, Liu J, Shen G. Foot-and-mouth disease virus VP1 protein fused with cholera toxin B subunit expressed in Chlamydomonas reinhardtii chloroplast. Biotechnol Lett. 2003; 25:1087–92.

Surzycki R, Greenham K, Kitayama K, Dibal F, Wagner R, Rochaix JD, et al. Factors effecting expression of vaccines in microalgae. Biologicals. 2009; 37:133–8.

Streatfield SJ, Jilka JM, Hood EE, Turner DD, Bailey MR, Mayor JM, et al. Plant-based vaccines: unique advantages. Vaccine. 2001; 19: 2742-8.

Amir Ghaffar S, Abdolreza B, Mohammad Reza B, Saeid M-S, Alireza A, Ali N. Expression of Hemagglutinin-Neuraminidase and fusion epitopes of Newcastle Disease Virus in transgenic tobacco. Electronic Journal of Biotechnology. 2016;22 (2016):38-43.

Habibi-Pirkoohi M, Mohkami A. Recombinant Vaccine Production in Green Plants: State of Art. J Cell Mol Res. 2015; 7(1): 59-67.

Yusibov V, Hooper DC, Spitsin SV, Fleysh N, Kean RB, Mikheeva T, et al. Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine. Vaccine. 2002; 20: 3155-64.

Dalsgaard K, Uttenthal A, Jones TD, Xu F, Merryweather A, Hamilton WD, et al. Plant-derived vaccine protects target animals against a viral disease. Nature biotechnol. 1997;15(3):248-52.

Orzaez D, Mirabel S, Wieland WH. Agroinjection of tomato fruits. A tool for rapid functional analysis of transgenes directly in fruit. Plant Physiol. 2006; 140(1): 3-11.

Mett V, Musiychuk K, Bi H, Farrance CE, Horsey A, Ugulava N, et al. A plant-produced influenza subunit vaccine protects ferrets against virus challenge. Influenza Other Respir Viruses. 2008; 2(1): 33-40.

Habibi-Pirkoohi M, Malekzadeh-Shafaroudi S, Marashi H, Moshtaghi N, Nasiri M, Zibaee S. Transient Expression of Foot and Mouth Disease Virus (FMDV) Coat Protein in Tobacco (Nicotiana tabacom) via Agroinfiltration. Iran J Biotechnol. 2014; 12(3): 1015-22.

Gleba Y, Klimyuk V, Marillonnet S. Magnifection--a new platform for expressing recombinant vaccines in plants. Vaccine. 2005; 23(17-18): 2042-8.

Kang TJ, Loc NH, Jang MO. Expression of the B subunit of E. coli heat-labile enterotoxin in the chloroplasts of plants and its characterization. Transgenic Res. 2003; 12(6): 683-91.

Chikwamba R, McMurray J, Shou H, Frame B, Pegg SE, Scott P, et al. Expression of a synthetic E. coli heat-labile enterotoxin B sub-unit (LT-B) in maize. Mol Breed. 2002;10(4):253-65.

Jabeen R, Khan MS, Zafar Y, Anjum T. Codon optimization of cry1Ab gene for hyper expression in plant organelles. Mol Biol Rep. 2010; 37(2):1011-7.

Fuhrmann M, Oertel W, Hegemann P. A synthetic gene coding for the green fluorescent protein (GFP) is a versatile reporter in Chlamydomonas reinhardtii. Plant J. 1999; 19: 353–61.

Gustafsson C, Govindarajan S, Minshull J. Codon bias and heterologous protein expression. Trends Biotechnol. 2004; 22(7):346-53.

De Angioletti M, Lacerra G, Sabato V, Carestia C. β+ 45 G→ C: a novel silent β‐thalassaemia mutation, the first in the Kozak sequence. Br J Haematol. 2004; 124(2) :224-31.

Gallie D. The 5’leader of tobacco mosaic virus promotes translation through enhanced recruitment of eIF4F. Nucleic Acids Res. 2002; 30(15): 3401–11.

Xu J, Ge X, Dolan MC. Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures. Biotechnol Adv. 2011; 29:278–99.

Haq TA, Mason HS, Clements JD, Arntzen CJ. Oral immunization with a recombinant bacterial antigen produced in transgenic plants. Science. 1995;268(5211):714.

He X, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Kermode AR. Influence of an ER-retention signal on the N-glycosylation of recombinant human α-L-iduronidase generated in seeds of Arabidopsis. Plant Mol Biol. 2012;79(1-2):157-69.

Daniell H, Streatfield SJ, Wycoff K. Medical molecular farming: production of antibodies, biopharmaceuticals and edible vaccines in plants. Trends Plant Sci. 2001;6(5):219-26.

Ruhlman T, Verma D, Samson N, Daniell H. The role of heterologous chloroplast sequence elements in transgene integration and expression. Plant physiol. 2010; 152(4):2088-104.

Carter III JE, Langridge WH. Plant-based vaccines for protection against infectious and autoimmune diseases. Crit Rev Plant Sci. 2002;21(2):93-109.

Mason HS, Warzecha H, Mor T, Arntzen CJ. Edible plant vaccines: applications for prophylactic and therapeutic molecular medicine. Trends Mol Med. 2002;8(7):324-9.

Zhang L, Zhang J, Chen HT, Zhou JH, Ding YZ, Liu YS. Research in advance for FMD novel vaccines. Virol J. 2011 ;8(1):1.

Paul MJ, Thangaraj H, Ma JK. Commercialization of new biotechnology: a systematic review of 16 commercial case studies in a novel manufacturing sector. Plant Biotechnol J. 2015; 13(8):1209-20.

Gopalakrishnan M, Libby T, Samuels JA, Swenson D. The effect of cost goal specificity and new product development process on cost reduction performance. Accounting, Organizations and Society. 2015;42:1-11.

Felekoglu B, Moultrie J. Top management involvement in new product development: A review and synthesis. Journal of Product Innovation Management. 2014;31(1):159-75.

Frost FA. New Product Development-Biotechnology in Australia. InGlobal Perspectives in Marketing for the 21st Century 2015 (pp. 287-296). Springer International Publishing.

Bendoly E, Bharadwaj A, Bharadwaj S. Complementary Drivers of New Product Development Performance: Cross‐Functional Coordination, Information System Capability, and Intelligence Quality. Production and Operations Management. 2012;21(4):653-67.

Deeds DL, Hill CW. Strategic alliances and the rate of new product development: an empirical study of entrepreneurial biotechnology firms. J Business Venturing. 1996;11(1):41-55.

Xu J, Dolan MC, Medrano G, Cramer CL, Weathers PJ. Green factory: plants as bioproduction platforms for recombinant proteins. Biotechnol Adv. 2012;30(5):1171-84.

Deeds DL, DeCarolis D, Coombs J. Dynamic capabilities and new product development in high technology ventures: An empirical analysis of new biotechnology firms. Journal of Business venturing. 2000;15(3):211-29.

Bailey AM, Mendicino M, Au P. An FDA perspective on preclinical development of cell-based regenerative medicine products. Nat. Biotechnol. 2014;32(8):721-3.

Hawkes C, Thow AM, Downs S, Ling AL, Ghosh-Jerath S, Snowdon W, et al. Identifying effective food systems solutions for nutrition and noncommunicable diseases: creating policy coher-ence in the fats supply chain. SCN News. 2013; (40):39-47.

Seuring S. A review of modeling approaches for sustainable supply chain management. Decision support systems. 2013 ;54(4):1513-20.

Isaksson OH, Simeth M, Seifert RW. Knowledge spillovers in the supply chain: Evidence from the high tech sectors. Research Policy. 2016;45(3):699-706.

Pavlou AK, Reichert JM. Recombinant protein therapeutics—success rates, market trends and values to 2010. Nat. biotechnol. 2004;22(12):1513-9.

Huang CJ, Lowe AJ, Batt CA. Recombinant immunotherapeutics: current state and perspectives regarding the feasibility and market. Appl Microbiol Biotechnol. 2010;87(2):401-10.

Vigani M, Olper A. GMO standards, endogenous policy and the market for information. Food Policy. 2013;43:32-43.

Twardowski T, Małyska A. Uninformed and disinformed society and the GMO market. Trend. Biotechnol. 2015;33(1):1-3.

Mason HS. Recombinant immune complexes as versatile and potent vaccines. Hum Vaccin Immunother. 2016;12(4):988-9.

Marsian J, Lomonossoff GP. Molecular pharming—VLPs made in plants. Current. Opin. Biotechnol. 2016;37:201-6.

Mardanova ES, Kotlyarov RY, Kuprianov VV, Stepanova LA, Tsybalova LM, Lomonossoff GP, et al. High immunogenicity of plant-produced candidate influenza vaccine based on the M2e peptide fused to flagellin. Bioengin. 2016;7(1):28-32.

Boes A, Reimann A, Twyman RM, Fischer R, Schillberg S, Spiegel H. A Plant-Based Transient Expression System for the Rapid Production of Malaria Vaccine Candidates. Methods Mol Biol. 2016;1404:597-619.

Blagborough AM, Musiychuk K, Bi H, Jones RM, Chichester JA, Streatfield S, et al. Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax. Vaccine. 2016;34(28):3252-9.

Menzel S, Holland T, Boes A, Spiegel H, Bolzenius J, Fischer R, et al. Optimized Blanching Reduces the Host Cell Protein Content and Substantially Enhances the Recovery and Stability of Two Plant-Derived Malaria Vaccine Candidates. Front Plant Sci. 2016;7:159.

Monreal-Escalante E, Govea-Alonso DO, Hernández M, Cervantes J, Salazar-González JA, Romero-Maldonado A, et al. Towards the development of an oral vaccine against porcine cysticercosis: expression of the protective HP6/TSOL18 antigen in transgenic carrots cells. Planta. 2016;243(3):675-85.

Kalbina I, Lagerqvist N, Moiane B, Ahlm C, Andersson S, Strid Å, et al. Arabidopsis thaliana plants expressing Rift Valley fever virus antigens: Mice exhibit systemic immune responses as the result of oral administration of the transgenic plants. Protein Express Pur. 2016;127:61-7.


  • There are currently no refbacks.